Royalty Pharma plc
Royalty Pharma plc (RPRX) — Form 144: Proposed sale of shares
About this filing
Royalty Pharma plc (RPRX) filed Form 144 (proposed sale of shares) with the SEC on Sep 28, 2026. Form 144 is notice that an insider or affiliate plans to sell shares.
Key facts
- Seller
- Urist Marshall
- Relationship
- Officer
- Shares to sell
- 4,126
- Market value
- $238,812.88
- Approximate sale date
- Sep 28, 2026
- Broker
- Merrill Lynch
- Acquired
- Aug 5, 2026 · Equity Performance Award
Rule 10b5-1 plan · adopted Jun 26, 2026
More RPRX filings
- 8-K
Filed Nov 4, 2026
- 4
Filed Oct 5, 2026
- 144
Filed Oct 5, 2026
- 4
Filed Sep 30, 2026
- 4
Filed Sep 30, 2026
- 4
Filed Sep 24, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.